Gideon Ampoma Gyebi

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL^pro): an<i>in silico</i>screening of alkaloids and terpenoids from African medicinal plants

Gideon Ampoma Gyebi, Olalekan Bukunmi Ogunro, Adegbenro P. Adegunloye et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 201 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth

Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Afolabi Olanrewaju Saheed et al. · Frontiers in Molecular Biosciences · 2022 · 106 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti et al. · ASN NEURO · 2021 · 90 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +17

Identification of promising multi-targeting inhibitors of obesity from Vernonia amygdalina through computational analysis

Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Ibrahim M. Ibrahim et al. · Molecular Diversity · 2022 · 50 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Prevention of SARS-CoV-2 cell entry: insight from<i>in silico</i>interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2

Gideon Ampoma Gyebi, Adegbenro P. Adegunloye, Ibrahim M. Ibrahim et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 49 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16